Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation
Li Wen, Dong Xingtong, Jia Qiang, Fu Wenjing, Lin Na, Liu Hua, Zhang Aihua
Chinese Journal of Nephrology . 2020, (10): 744 -749 .  DOI: 10.3760/cma.j.cn441217-20191101-00132